Drug-induced liver injury due to "natural products" used for weight loss: A case report

World Journal of Gastroenterology

Volumn 15, Issue 19, 2009, Pages 2414-2417

  Tarantino, Giovanni ^a   Pezzullo, Martina Gilda ^a   di Minno, Matteo Nicola Dario ^a   Milone, Francesco ^a   Pezzullo, Luigi Sossio ^a   Milone, Marco ^a   Capone, Domenico ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Department of General Surgery   (Italy)

Author keywords

Cholecystitis; Drug induced liver injury; Herbal remedies; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CILASTATIN PLUS IMIPENEM; GAMMA GLUTAMYLTRANSFERASE; HERBACEOUS AGENT; PARACETAMOL;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ABNORMAL FECES; ABNORMAL URINE COMPOSITION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLELITHIASIS; CHOLESTASIS; CLINICAL FEATURE; DRUG INDUCED DISEASE; DYSMENORRHEA; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HERBAL MEDICINE; HUMAN; JAUNDICE; LIVER INJURY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NAUSEA; PHYTOTHERAPY; POSTOPERATIVE PERIOD; PRURITUS; TREATMENT INDICATION; ULTRASOUND; VOMITING; WEIGHT REDUCTION;

EID: 67651250138     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2414     Document Type: Article

References (15)

1. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330
2. Conti E, De Checchi G, Mencarelli R, Pinato S, Rovere P. Lycopodium similiaplex-induced acute hepatitis: a case report. Eur J Gastroenterol Hepatol 2008; 20: 469-471
3. Stickel F, Pöschl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003; 38: 565-568
4. Crijns AP, de Smet PA, van den Heuvel M, Schot BW, Haagsma EB. [Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)] Ned Tijdschr Geneeskd 2002; 146: 124-128
5. Kosina P, Walterová D, Ulrichová J, Lichnovský V, Stiborová M, Rýdlová H, Vicar J, Krecman V, Brabec MJ, Simánek V. Sanguinarine and chelerythrine: assessment of safety on pigs in ninety days feeding experiment. Food Chem Toxicol 2004; 42: 85-91
6. Takayama H, Katakawa K, Kitajima M, Yamaguchi K, Aimi N. Ten new Lycopodium alkaloids having the lycopodane skeleton isolated from Lycopodium serratum Thunb. Chem Pharm Bull (Tokyo) 2003; 51: 1163-1169
7. Woolf GM, Petrovic LM, Rojter SE, Wainwright S, Villamil FG, Katkov WN, Michieletti P, Wanless IR, Stermitz FR, Beck JJ, Vierling JM. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994; 121: 729-735
8. Choy CS, Cheah KP, Chiou HY, Li JS, Liu YH, Yong SF, Chiu WT, Liao JW, Hu CM. Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration. J Appl Toxicol 2008; 28: 945-956
9. Stickel F, Egerer G, Seitz HK. Hepatotoxicity of botanicals. Public Health Nutr 2000; 3: 113-124
10. Gordon DW, Rosenthal G, Hart J, Sirota R, Baker AL. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273: 489-490
11. Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity. Ann Intern Med 2001; 135: 68-69
12. Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci 2000; 56: 424-430
13. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002; 177: 440-443
14. Lake CR, Gallant S, Masson E, Miller P. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990; 89: 195-208
15. Sanchez W, Maple JT, Burgart LJ, Kamath PS. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc 2006; 81: 541-544